The BioCalendar

Bio on the Bay
2022-03-17 17:00 - 19:00 UTC
A bit of malarkey and lots of green beer, make no mistake you’ll want to be here. Join CLS and Lonza for our annual Bio on the Bay, an informal networking event for the life sciences community.
This event is closed to service provider companies that are not members of California Life Sciences. To become a member, click here.
To ensure a safe and enjoyable experience for everyone, please review our event safety protocols prior to the event.

Fierce BD&L Summit for Life Sciences
2022-03-15 - 2022-03-16
The Fierce Business Development and Licensing (BD&L) Summit for Life Sciences returns LIVE in 2022 bringing together key deal-makers and serving as an open forum for cross-functional business development, due diligence, finance, and legal teams to share valuable insights and actionable strategies on successfully sourcing and evaluating new opportunities, conducting due diligence, and structuring licensing agreements and M&A deals. This year’s conference features expanded networking opportunities along with two days of panels, case studies, and practical sessions across three critical topic areas – Business Development, Due Diligence, and Legal/IP.

OPT Congress 2022
2022-03-15 - 2022-03-16
OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. We bring together leading discovery and development scientists, CMC and regulatory experts, and technology providers, to help you optimize drug design and delivery, streamline manufacturing and regulatory issues and accelerate time to market.

BioscienceLA.TV Proudly presents Camera Ready
2022-03-10 00:00 - 23:59 UTC
Three Events In One!
Improve your media skills, update your headshot/record your video pitch AND network with your fellow professionals as part of LAMedTechWeek.
Mar 10, 1:00 PM – 7:00 PM PST
Media Training & A Professional Headshot ONLY $99
Receive access to three hours of media training from our exclusive team of experts AND a professional headshot photo at BioscienceLA in-person on March 10th with a “Media Savvy Ticket”.*
The total value of this package is $299 so grab your $99 tickets while they last!
*You will receive your retouched photo by March 17th.

BioCapital Europe 2022
2022-03-10
We are delighted to announce BioCapital Europe 2022 will be taking place in person on March 10th 2022 at Hotel Sofitel Legend The Grand Amsterdam.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe.
In 2021 our virtual conference attracted over 600 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.
Make sure to save the date, March 10th 2022 and we look forward to seeing you in person!
Programme announced soon.

The Protein Degradation and Targeting Undruggables Summit
2022-03-07 - 2022-03-10
The Protein Degradation and Targeting Undruggables Summit is the only industry-led forum giving you in-person insight into the full range of novel therapeutic approaches targeting the undruggable and expanding the scope of therapeutically reachable targets. Entering its 3rd edition, this event will take place over two face-to-face days in Boston (8-9 March 2022) and two digital days (7 & 10 March 2022) and will allow you to have in-depth conversations on the latest in vitro and in vivo data driving forward the translation of undrugged research into clinically and commercially viable products.

Tell Me About Your DE&I Initiatives, a Leadership Panel
2022-03-04 08:30 - 10:00 UTC
Tell Me About Your Diversity, Equity & Inclusion Initiatives, is the evolution of the successful LSPA Tell Me About Your Job Series. This reimagined series will pivot focus from specific career paths to spotlighting organizations in the Life Sciences. Highlighted on the virtual program will be leaders from across the industry discussing their culture, hiring practices, and managing the changing landscape of the workforce.
AGENDA:
8:30 am – Program opens; Casual networking
8:45 am – Panel Discussion

Natasha Berry, Vice President of Inclusion Culture, Diversity & Equity, Smith + Nephew

Jasmin Senior Bostic, Associate Director, Global Early Careers Program (US & EMEA), CSL Behring

Nithya Srinivasan, Director of Marketing, Rheumatology, Janssen

9:30 am – Networking in Breakout Rooms
10:00 am – Program Concludes
For General Program Questions or Sponsorship Opportunities: Please contact Jill Huber, Director of Programs, jhuber@lifesciencespa.org.

2022 Epilepsy Pipeline Conference
2022-03-03 - 2022-03-04
This premiere event is held every two years to bring together decision-makers in the field of epilepsy treatment, therapeutic innovation, and product development. This exciting meeting provides a forum for evaluating new therapies in development, exploring future advancements, and encouraging collaborations and partnerships.

Advancing R&D in Gene Therapy
2022-03-02 19:30 - 21:30 UTC
Gene therapies provide patients with unique treatments for traditionally incurable diseases, particularly in the oncology space. However, the vast complexities of biology and novel nature of this research requires innovative approaches to build a complete picture of disease mechanisms. Join us to explore the current hurdles in gene therapy research and how we as an industry can advance therapies and improve care.
Discussion topics will include:

Uncovering the influence of tissue architecture on cancer progression, immune infiltration, and therapeutic response by combining histology with spatially resolved whole transcriptome analysis in tissue sections
Identifying novel and rare cell types and states associated with tumor progression and metastasis that were previously masked by bulk analysis methods
Investigating how alterations in epigenetic architecture lead to transcriptional heterogeneity, resulting in diversity of cell types, states, and dynamics in the tumor microenvironment
Optimizing cell and gene therapies with single cell multiomics

WIB-Greater Boston: Creating Inclusive Culture – Action Items for Individuals, Managers, Organizations
2022-03-01 17:30 - 18:30 UTC
In the current alignment of the #MeToo, #BlackLivesMatter, and COVID’s #GreatResignation movements, individuals and organizations may finally be ready to address the challenges of true inclusivity and diversity. This is the right thing to do, and it’s about time. The era is gone where we refer to our people as FTEs (full-time equivalents) like another piece of equipment. The time is here for creating cultures that attract and retain a company’s most important resource, its people. The mountain seems high. Where should you start? Join us for this program to talk about the best starting points for individuals, managers, and leaders in driving this change.
Disclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable, please be sure to turn off your webcam.
Program
5:30 p.m. – 5:35 p.m. Welcome & Speaker Introduction
5:35 p.m. – 6:30 p.m. DEI Presentation & Discussion

BVS’ Outdoor Biotech Community Event at SOVA Science District
2022-03-01 16:00 - 18:30 UTC
We are very excited to announce our outdoor Biotech Community Event at SOVA Science District.
Our last event was a HUGE success with 250 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend.
The event is being promoted as a special Biotech Community Event sponsored by the best scientific suppliers in the industry along with it being a wonderful way for scientists and science vendors to network in a relaxed evening venue.
The event will be a combination of vendor exhibits, tacos and beer. We will have extra special raffle prizes and expect an excellent turnout.

2022 Rare Disease Day
2022-02-28 10:00 - 12:30 UTC
MassBio recognizes Rare Disease Day by highlighting the research to treat and cure rare diseases happening in Massachusetts. The last day of February has been designated as Rare Disease Day worldwide to raise awareness about the public health issues associated with rare diseases, which affect nearly 30 million Americans and countless others around the world.
This year’s program will focus on how we can better address health inequity and racial disparities among the rare disease community. Attendees will hear an inspiring Possible Talk, an insightful panel of industry, physicians, patients/caregivers, and advocates, along with a closing patient keynote. Ample networking time will be provided (virtually, too!).

Pennsylvania Rare Disease Day
2022-02-28 08:30 - 11:00 UTC
The Pennsylvania Rare Disease Day event is to empower rare disease patients to effectively share their stories and gain the knowledge around the legislative process to influence change. We have the additional goal of educating and informing our legislators on issues affecting rare disease patients, and how they too can most effectively work with them to provide better outcomes throughout the Commonwealth.
Rare disease patients throughout Pennsylvania are faced with unique, often life-threatening challenges each and every day. Of the nearly 10,000 rare diseases in the US, only a few hundred have any established treatment. Life Sciences PA, in partnership with the National Organization for Rare Disorders (NORD) and the Pennsylvania Rare Disease Advisory Council (PARDAC), invite you to join us in this very important discussion as we understand the challenges facing the rare disease community throughout the Commonwealth, discuss the path forward, and work together to create the innovative ecosystem that rare disease patients depend on.
Agenda:
8:30 a.m. – 8:40 a.m. – Welcome by Life Sciences PA President and CEO, Christopher P. Molineaux
8:45 a.m. – 9:25 a.m. – Panel Discussion around the Orphan Drug Tax Credit and proposed changes
9:30 a.m. – 10:00 a.m. – Update on The Bespoke Gene Therapy Consortium (BGTC)
10:05 a.m. – 10:45 a.m. – Impact of Newborn Screening Bill in PA
10:50 a.m. – 11:00 a.m. – Update from PARDAC, Invitation to Press Conference
If you have any questions about the event, please contact Nicole Oshurak, Vice President, State Policy & Public Affairs, Noshurak@lifesciencespa.org

Halloran Town Hall | Hybrid Models and the Path to Designing Patient-Centric Clinical Trials
2022-02-25 11:00 - 12:00 (America/New_York)
Patient centricity, at its core, is bringing the voice of the patient into clinical trial design right from the start to ensure the trial can achieve its objectives and endpoints while also creating a positive experience for the patients and their families. But what patient-centricity really means and what it looks like in trial design is commonly misunderstood, and unfortunately, there are major risks for sponsors and patients when the understanding isn’t aligned.
Please join our Halloran-hosted virtual Town Hall on February 25th from 11-12 pm ET on “Hybrid Models and the Path to Designing Patient-Centric Clinical Trials” to align on the opportunities and value of building patient-centric principles into hybrid clinical trials.
This discussion will be led by team members at Halloran and joined by clinical operations executives and a patient to bring perspective to the following:
Defining patient centricity in clinical trial design and the risks of poor implementation
How hybrid model trials and technology elevate patient centricity tactics in clinical trial design
Hear a patient’s perspective about how hybrid trials are less burdensome
Understand strategies, tactics, and tools sponsor companies can use regardless of their budget
Identify common missteps sponsors make in designing their studies that might undermine patient centricity
The Panel:
Jennie Sheridan, Halloran Consulting Group, Moderator
John Ferraro, Halloran Consulting Group
Jane Myles, VP, Clinical Trial Innovation, Curebase
Mari Maurer, Vice President of Clinical Operations, Escape Bio
Alicia C. Staley, VP of Patient Engagement, Medidata Solutions

SoCalBio Networking Forum
2022-02-24 16:00 - 18:00 UTC
The longest running health and bioscience mixer in Southern California – starts 1pm PST, 4pm EST

This event will showcase drug delivery as a bridge that tie biotechnology and medical devices. It is also an area of competence in Greater Los Angeles where many companies made their fortunes, e.g. MiniMed (using pumps to deliver insulin) and Abraxis Biosciences (Using albumin-encapsulated paclitaxel for treating breast cancer).
The event will also feature presentations and discussions about novel micro bots, smart pumps, and novel polymers by Bionaut Labs (West Los Angeles, CA), Cognos Therapeutics (Hawthorne, CA), and Dyve Biosciences (Camarillo, CA) respectively. These companies represent a new generation of drug delivery companies that advantage of new advances in science and technology to develop devices intended for smart, safe, and controlled drug delivery of, not just small molecules, but also biologics.

3RD DIGITAL MARKETING IN LIFE SCIENCES
2022-02-24 09:00 - 2022-02-25 16:00 (America/New_York)
Digital marketing is a field in which things are constantly progressing and changing, and it’s crucial to stay updated. At the 2nd Digital Marketing in Life Sciences Conference, you will walk away with the ability to transform the way brands communicate with customers/patients, increase transparency, engage, and grow. With the advancements in information sharing platforms, consumers have 24/7 access to information, health resources, health records, always in their pockets, the future of Digital Marketing is here.
Join those that touch the spectrum of the business to address current regulations, technologies, strategic digital marketing techniques and issues that the life sciences face daily. Hear from subject matter experts and true innovators in the digital health market at this wonderful conference. Learn how to create effective campaigns and hear exciting developments in the digital space from those transforming the industry.
This event will cover a broad spectrum of marketing techniques used by pharmaceutical, biotechnology and medical device companies and curated to showcase how to make big idea topics, actionable. Through the use of case studies, the speakers will share their experiences implementing different marketing techniques, which will include digital transformation, content strategies, social media marketing, new technologies, patient and customer engagement and more. The digital community will walk away looking to advance the work that they do at this 2nd Digital Marketing in Life Sciences Conference.

The Texas Life Science Forum
2022-02-24 08:30 - 18:00 UTC
The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. The 10th Annual conference will be held in person in February 2022 on campus at Rice University and is a chance to meet investors, learn about promising life science companies and hear about opportunities for entrepreneurs, investment professionals, big pharma, academics and business executives serving the life science industry.

QB3 Webinar: Christopher Garcia, Stanford
2022-02-23 16:00 - 17:00 UTC
Natural and Engineered Cell Surface Receptor-Ligand Interactions in Human Health and Disease
About this event
Christopher Garcia is interested in cell surface receptors and their ligands. Garcia and his team at Stanford investigate how ligand recognition and signaling coordinate with the cell physiology to determine function and fate. In addition to understanding basic aspects of receptor signaling and structure, the team uses protein engineering to create novel receptor ligands. A major aim of their work is to leverage natural signaling mechanisms as a path to potential therapeutics. Garcia has founded or co-founded several companies, including ALXO (SIRP/CD7 antagonist), Synthekine (cytokine engineering), Surrozen (Wnt agonists), 3T (TCR antigen discovery), and Mozart (immune modulation by regulatory T cells).

Biocom California’s Global Life Science Partnering Conference
2022-02-22 - 2022-02-24
Biocom California’s 12th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us in San Diego, February 22th to February 28th, 2022, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers.
The Global Life Science Partnering Conference will be held both in person and virtually, so you can choose how you want to experience the event based on your comfort level. The staff at Biocom California are closely monitoring the spread of the Omicron variant and are working hard to ensure that your conference experience is meaningful and valuable to attend, whether you are joining us live or remotely. Our plans for a hybrid experience are based on best practices and recommendations from the CDC, and information from local public health professionals.
**The registration price of the conference does not change, regardless of your attendance status.
All in person attendees will be required to be fully vaccinated and provide proof of vaccination. Please see the COVID-19 page for more detailed information.
What Your In-Person Attendance Includes:

Access to live one-on-one partnering meetings on Wednesday, February 23rd and Thursday, February 24th, 2022. Meetings will be held from 7am to 5pm both days.
Real-time access to all panel discussions, keynotes and fireside chat presentations, and company presentations.
Attendance to all networking receptions and events, which include, opening welcome reception, gala reception, and closing reception. Hosted food and beverages provided at all receptions.
Breakfast and lunch provided on Wednesday and Thursday.

What Your Virtual Attendance Includes:

Access to virtual one-on-one partnering meetings on Monday, February 21st, Tuesday, February 22nd and Friday, February 25th, 2022. Meetings will be expanded to a 24-hr timeframe to accommodate and facilitate meetings with delegates from around the world.
On-demand content of all panel discussions, keynotes and fireside chat presentations, and company presentations. All content will be released no later than Tuesday, March 1st, 2022 and will be available up to 30 days post-conference.

AGENDA

Molecular & Precision Med Tri-Con
2022-02-21 - 2022-02-23
TRI-CON 2022:
Driving Innovation and Collaboration
in Diagnostics and Precision Medicine
Over the past 28 years, the Tri-Conference has served as the leading international meeting place for the precision medicine community. As the world faces the challenges from the pandemic recovery, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2022. Join thousands of international thought leaders —in-person and/or virtually— to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis. Come to sunny San Diego for the in-person networking you’ve come to expect from the Tri-Conference; or join us virtually from the comfort of your home or office for online networking, the cutting-edge scientific program, and convenient on-demand viewing.

Legal Essentials for Life Science Entrepreneurs
2022-02-17 13:00 - 14:00 UTC
Biocom California in partnership with Nixon Peabody LLP invite you to join us for an enlightening presentation on “Legal Essentials for Life Sciences Entrepreneurs.” This webinar will cover what early-stage founders need to know to set their companies up for success.
During this virtual event, industry experts from Nixon Peabody will share key legal considerations that early-stage life sciences companies should incorporate into their growth strategies. Based on their collective experience serving as outside general counsel to emerging growth and mid-stage organizations regarding fundraising, intellectual property, regulatory issues, and workforce management, the attorneys will discuss insights and best practices for the journey, from formation to exit.

Celebrating Black History Month: Black Biotech Trailblazers in Life Science
2022-02-16 19:30 - 21:30 UTC
In honor of Black History Month, we will host a panel discussion made of up black biotech CEOs in the life science industry. Our panelists can share their obstacles and challenges, what inspired them in their journey and their hope for the future of biotech and life science.
Panelists:
Enoch Kariuki, Chief Executive Officer, Lengo Therapeutics
Stanley Lewis, Co-Founder, Chief Executive Officer, A28 Therapeutics
Paul Mola, President & CEO, Roswell Biotechnologies
Agenda (PST):
4pm: Registration Opens
4:30pm to 5:30pm: Panel Discussion
5:30pm to 6:30pm: Networking Reception

Virtual BioXchange - Feb 16th
2022-02-16 16:00 - 19:00 UTC
Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world.
BioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience.
Participants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room.
***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.

Halloran Speaker Series | Building and Leading Your Product Development Team: Skillsets, Challenges, and Solutions
2022-02-16 14:00 - 15:00 (America/New_York)
Biopharma development teams of all sizes require resources and direction as their programs move through each stage of development. Whether those resources are pulled from in-house or outsourced, a strong development team requires a particular structure and leader, providing measured guidance and critical support at key inflection points at every stage to ensure success and de-risk their programs.
Before a company fills those seats, they’ll need to identify the core job functions and skillsets for the essential roles they’re looking to fill. If your organization is starting to build its product development team or has gaps in its team or leadership, please join members of the Strategy and Program Leadership team at Halloran Consulting Group for a virtual Speaker Series on “Building and Leading Your Product Development Team: Skillsets, Challenges, and Solutions” on February 16th from 2-3 pm ET to hear their insight on this dynamic to optimize your organization.
Our panel of experts will discuss:
Essential roles that comprise a product development team while considering the company size
Core skillsets and responsibilities required for development team roles
The kind of experience and insight to look for in a development team leader
Expected challenges and common oversights development teams experience
We’re looking forward to an interactive discussion with our industry partners.
Hosted by:
Matt Cardinal, VP, Strategy & Program Leadership
Katy Georgiadis, Senior Consultant, Program Leader
Erika Dahl, Consultant, Strategy & Program Leadership
Carolina Ahrendt, Senior Consultant, Strategy & Program Leadership

SVB Leerink 11th Annual Global Healthcare Conference 2022
2022-02-14 - 2022-02-18
The SVB Leerink Corporate Events team curates differentiated and impactful events, engaging public and private companies, institutional investors, and an array of industry experts to discuss trends and opportunities that are shaping the future of healthcare and technology.
These exclusive interactions are facilitated through marquee events, thematic forums, and interactive series, executed throughout the U.S. and China, providing the ideal platform to connect and network.

BIO CEO & Investor Conference
2022-02-14 - 2022-02-17
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
Join us in 2022 – either in person or online – for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The Top 100 VCs in Biotech 2022
2022-02-10 14:00 - 15:00 UTC
Endpoints News and Chris Dokomajilar at DealForma are back with our annual breakdown of the top 100 VCs in biotech — a field that has undergone some dramatic changes in the past 5 years. Who’s a player? Who’s on the sidelines looking to jump in? Endpoints founder John Carroll will host a webinar looking at a fascinating piece of the funding scene in the industry with a roundtable discussion on piecing together the best syndicate in biotech.

Fireside Chat with Paul Edick, Chairman and CEO, Xeris BioPharma
2022-02-08 18:00 - 19:00 UTC
Featuring prominent biotech founders, executives, and VCs.

About this event

Featuring Paul Edick, Chairman & CEO, Xeris BioPharma
Mr. Edick joined Xeris BioPharma as Chairman and Chief Executive Officer in January 2017. Prior to Xeris, Mr. Edick was Founding Partner of 3G Advisors, a consultancy to the pharmaceutical, healthcare, and healthcare investor communities. From 2010 to 2014, Mr. Edick was the Chief Executive Officer of Durata Therapeutics (Nasdaq: DRTX), a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases. Durata was acquired by Actavis plc, now Allergan plc, in November 2014. Prior to Durata, Mr. Edick was Chief Executive Officer of Ganic Pharmaceuticals, a Warburg Pincus investment search vehicle, from 2008 to 2010. Before Ganic, Mr. Edick was Chief Executive Officer of MedPointe Healthcare, Inc., a US-based specialty pharmaceutical company, a position he assumed in 2006, having been President of Pharmaceutical Operations since 2002. Mr. Edick led the growth of the business and the development of a clinical stage portfolio, and the company was subsequently sold to Meda AB of Sweden in 2007.

The Road to Going Public and Beyond: Preparation starts now
2022-02-08 14:00 - 15:00 UTC
Going public is a transformative event for an organization that is complex, requires significant attention for executive management, involves the entire organization and carries high execution risk. Whether you go public via a direct listing IPO, a SPAC, or other reverse merger, the level of effort and the cost of preparation should not be underestimated. Beginning preparation early enables an organization to better manage both.
Join us on Tuesday, Feb. 8 to learn about the latest trends in the public markets as well as the steps you can take now to prepare your organization for an IPO when the market opportunity arises.
Your key takeaways from the event:

Considerations to prepare your organization for going public
How to assess overall readiness
How to identify organizational gaps to address
IPO and SPAC readiness timeline
Considerations for life as a public company

Date: Tuesday, February 8, 2022
Time: 2pm ET / 11am PT
Duration: 1 Hour

SCOPE Summit
2022-02-07 - 2022-02-10
Calculate. Accommodate. Innovate.
Now more than ever, the important work of this clinical research community requires collaboration and innovation. Now in its 13th year of fostering these goals, SCOPE Summit 2022 will take place February 7-10, 2022 in Orlando, FL at a new location, the Rosen Shingle Creek. Over four stimulating days of in-depth discussions in 22 different conferences, 3 plenary keynote sessions, the 6th annual Participant Engagement Awards, special cross-department panels, a first-time charity golf tournament, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations. SCOPE Virtual 2021 attracted more than 2,200 leaders in clinical operations and research, and we look forward to you and your team joining us in 2022!
